Physician profile
John A Charles
NPI 1962489716
$998.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $341.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $118.99 | 2019-2020 | |
| Eisai INC. | $95.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $85.72 | 2019-2020 | |
| Novo Nordisk INC | $82.34 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.53 | 2019-2020 | |
| Glaxosmithkline, LLC. | $60.72 | 2019-2020 | |
| Bausch Health US, LLC | $58.70 | 2019-2020 | |
| Lilly USA, LLC | $55.13 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.70 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $44.43 | 2019 | |
| Allergan, INC. | $42.38 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $36.98 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $34.42 | 2019 | |
| Amarin Pharma, INC. | $31.05 | 2019 | |
| Abbott Laboratories | $23.95 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $22.59 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.94 | 2019 | |
| Abbvie INC. | $18.41 | 2019 | |
| Amgen INC. | $17.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.66 | 2019 | |
| Ibsa Pharma INC. | $13.81 | 2020 | |
| Endo Pharmaceuticals INC. | $11.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.